Ahrong Ham
Mokdong, Republic of Korea
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications
Analysis of the Frequency and Associated Factors of Skin Toxicity in Patients Receiving Ribociclib-Based Therapy for Metastatic Breast Cancer.
Journal: Cancers
Published: April 09, 2026
Real-World Outcomes of Nivolumab, Pembrolizumab, and Atezolizumab Treatment Efficacy in Korean Veterans with Stage IV Non-Small-Cell Lung Cancer.
Journal: Cancers
Published: July 19, 2023
Intrahepatic cholangiocarcinoma initially diagnosed as adenocarcinoma of unknown primary with hepatoduodenal ligament lymph node metastases: A case report.
Journal: Oncology letters
Published: May 02, 2023
β‑catenin blockers enhance the effect of CDK4/6 inhibitors on stemness and proliferation suppression in endocrine‑resistant breast cancer cells.
Journal: Oncology reports
Published: January 27, 2022
Role of Preoperative Chemoradiotherapy in Clinical Stage II/III Rectal Cancer Patients Undergoing Total Mesorectal Excision: A Retrospective Propensity Score Analysis.
Journal: Frontiers in oncology
Published: September 23, 2020
Correction to: Palbociclib use with grade 3 neutropenia in hormone receptor-positive metastatic breast cancer.
Journal: Breast cancer research and treatment
Published: July 15, 2020
Recurrent meningococcal meningitis with complement 6 (C6) deficiency: A case report.
Journal: Medicine
Published: June 03, 2020
Palbociclib use with grade 3 neutropenia in hormone receptor-positive metastatic breast cancer.
Journal: Breast cancer research and treatment
Published: April 23, 2020
Functional characterization of genetic variations in the MDR3 promoter.
Journal: Biochemical and biophysical research communications
Published: December 01, 2012
Showing 1-10 of 10
Last Updated: 09/26/2026